We adapted a radioligand receptor binding assay for measuring insulin levels in unknown samples. The assay enables rapid and accurate determination of insulin concentrations in experimental samples, such as from insulin-secreting cells. The principle of the method is based on the binding competition of insulin in a measured sample with a radiolabeled insulin for insulin receptor (IR) in IM-9 cells. Both key components, radiolabeled insulin and IM-9 cells, are commercially available. The IR binding assay was used to determine unknown amounts of insulin secreted by MIN6 β cell line after stimulation with glucose, arginine, ornithine, dopamine, and serotonin. The experimental data obtained by the IR binding assay were compared to the results determined by RIA kits and both methods showed a very good agreement of results. We observed the stimulation of glucose-induced insulin secretion from MIN6 cells by arginine, weaker stimulation by ornithine, but inhibitory effects of dopamine. Serotonin effects were either stimulatory or inhibitory, depending on the concentration of serotonin used. The results will require further investigation. The study also clearly revealed advantages of the IR binding assay that allows the measuring of a higher throughput of measured samples, with a broader range of concentrations than in the case of RIA kits. The IR binding assay can provide an alternative to standard RIA and ELISA assays for the determination of insulin levels in experimental samples and can be especially useful in scientific laboratories studying insulin production and secretion by β cells and searching for new modulators of insulin secretion.

Department of Biochemistry Faculty of Science Charles University 12840 Prague 2 Czech Republic

Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences Flemingovo nám 2 116 10 Prague 6 Czech Republic

Zobrazit více v PubMed

Saltiel AR. Insulin signaling in health and disease. J Clin Invest. 2021;131:e142241.

Vafiadis P, Bennett ST, Todd JA, Nadeau J, Grabs R, Goodyer CG, et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet. 1997;15:289–92. PubMed DOI

Herring R, Jones RH, Russell-Jones DL. Hepatoselectivity and the evolution of insulin. Diabetes Obes Metab. 2014;16:1–8. PubMed DOI

Bryant NJ, Gould GW. Insulin stimulated GLUT4 translocation - size is not everything! Curr Opin Cell Biol. 2020;65:28–34. PubMed DOI

Brody HDS, Greenbaum S, Gravitz L, Mandrup-Poulsen T, Scully T, Dolgin E, et al. Diabetes. Nature. 2012;485(Suppl. to 17 May):S1–S19. PubMed

Boucher J, Kleinridders A, Kahn CR. Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb Perspect Biol. 2014;6:a009191. PubMed DOI PMC

Braun M, Ramracheya R, Rorsman P. Autocrine regulation of insulin secretion. Diabetes Obes Metab. 2012;14:143–51. PubMed DOI

Rorsman P, Braun M. Regulation of insulin secretion in human pancreatic islets. Annu Rev Physiol. 2013;75:155–79. PubMed DOI

Rutter GA, Pullen TJ, Hodson DJ, Martinez-Sanchez A. Pancreatic beta-cell identity, glucose sensing and the control of insulin secretion. Biochem J. 2015;466:203–18. PubMed DOI

Shen YX, Prinyawiwatkul W, Xu ZM. Insulin: a review of analytical methods. Analyst. 2019;144:4139–48. PubMed DOI

Dzianova P, Asai S, Chrudinova M, Kosinova L, Potalitsyn P, Sacha P, et al. The efficiency of insulin production and its content in insulin-expressing model beta-cells correlate with their Zn(2+) levels. Open Biol. 2020;10:200137. PubMed DOI PMC

Jiracek J, Zakova L, Marek A. Radiolabeled hormones in insulin research, a minireview. J Labelled Compd Rad. 2020;63:576–81.

Gavin JR III, Gorden P, Roth J, Archer JA, Buell DN. Characteristics of the human lymphocyte insulin receptor. J Biol Chem. 1973;248:2202–7. PubMed DOI

Gorden P, Gavin JR 3rd, Kahn CR, Archer JA, Lesniak M, Hendricks C, et al. Application of radioreceptor assay to circulating insulin, growth hormone, and to their tissue receptors in animals and man. Pharmacol Rev. 1973;25:179–87. PubMed

Gavin JR 3rd, Kahn CR, Gorden P, Roth J, Neville DM Jr. Radioreceptor assay of insulin: comparison of plasma and pancreatic insulins and proinsulins. J Clin Endocrinol Metab. 1975;41:438–45. PubMed DOI

Suzuki K, Ohsawa N, Kosaka K. Radioreceptor assay for insulin. J Clin Endocrinol Metab. 1976;42:399–402. PubMed DOI

Kabuto M, Suzuki K, Ohsawa N, Kosaka K. A radioreceptor assay for insulin: direct measurement of dog pancreatic vein serum insulin. Endocrinol Jpn. 1977;24:173–8. PubMed DOI

Gavin JR 3rd, Trivedi B, Daughaday WH. Homologous IM-9 lymphocyte radioreceptor and receptor modulation assays for human serum growth hormone. J Clin Endocrinol Metab. 1982;55:133–9. PubMed DOI

Ilondo MM, Vanderschueren-Lodeweyckx M, De Meyts P. Measuring growth hormone activity through receptor and binding protein assays. Horm Res. 1991;36(Suppl. 1):21–6. PubMed DOI

Palivec V, Viola CM, Kozak M, Ganderton TR, Krizkova K, Turkenburg JP, et al. Computational and structural evidence for neurotransmitter-mediated modulation of the oligomeric states of human insulin in storage granules. J Biol Chem. 2017;292:8342–55. PubMed DOI PMC

Solinova V, Zakova L, Jiracek J, Kasicka V. Pressure assisted partial filling affinity capillary electrophoresis employed for determination of binding constants of human insulin hexamer complexes with serotonin, dopamine, arginine, and phenol. Anal Chim Acta. 2019;1052:170–8. PubMed DOI

Brezina K, Duboue-Dijon E, Palivec V, Jiracek J, Krizek T, Viola CM, et al. Can arginine inhibit insulin aggregation? A combined protein crystallography, capillary electrophoresis, and molecular simulation study. J Phys Chem B. 2018;122:10069–76. PubMed DOI

Miyazaki JI, Araki K, Yamato E, Ikegami H, Asano T, Shibasaki Y, et al. Establishment of a pancreatic beta-cell line that retains glucose-inducible insulin-secretion - special reference to expression of glucose transporter isoforms. Endocrinology. 1990;127:126–32. PubMed DOI

Merglen A, Theander S, Rubi B, Chaffard G, Wollheim CB, Maechler P. Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells. Endocrinology. 2004;145:667–78. PubMed DOI

Carlsson A, Hallgren IB, Johansson H, Sandler S. Concomitant enzyme-linked immunosorbent assay measurements of rat insulin, rat C-peptide, and rat proinsulin from rat pancreatic islets: effects of prolonged exposure to different glucose concentrations. Endocrinology. 2010;151:5048–52. PubMed DOI

Morcavallo A, Genua M, Palummo A, Kletvikova E, Jiracek J, Brzozowski AM, et al. Insulin and insulin-like growth factor II differentially regulate endocytic sorting and stability of insulin receptor isoform A. J Biol Chem. 2012;287:11422–36. PubMed DOI PMC

Korinek M, Sistek V, Mladkova J, Mikes P, Jiracek J, Selicharova I. Quantification of homocysteine-related metabolites and the role of betaine-homocysteine S-methyltransferase in HepG2 cells. Biomed Chromatogr. 2013;27:111–21. PubMed DOI

Malaguarnera R, Sacco A, Voci C, Pandini G, Vigneri R, Belfiore A. Proinsulin binds with high affinity the insulin receptor isoform a and predominantly activates the mitogenic pathway. Endocrinology. 2012;153:2152–63. PubMed DOI

Luisier S, Vital-Shmilovici M, Weiss MA, SBH K. Total chemical synthesis of human proinsulin. Chem Commun. 2010;46:8177–9. DOI

Roderigo-Milne H, Hauge-Evans AC, Persaud SJ, Jones PM. Differential expression of insulin genes 1 and 2 in MIN6 cells and pseudoislets. Biochem Biophys Res Commun. 2002;296:589–95. PubMed DOI

Wu GY, Bazer FW, Davis TA, Kim SW, Li P, Rhoads JM, et al. Arginine metabolism and nutrition in growth, health and disease. Amino Acids. 2009;37:153–68. DOI

Liu Z, Jeppesen PB, Gregersen S, Chen X, Hermansen K. Dose- and glucose-dependent effects of amino acids on insulin secretion from isolated mouse islets and clonal INS-1E beta-cells. Rev Diabet Stud. 2008;5:232–44. PubMed DOI

Smith PA, Sakura H, Coles B, Gummerson N, Proks P, Ashcroft FM. Electrogenic arginine transport mediates stimulus-secretion coupling in mouse pancreatic beta-cells. J Physiol-London. 1997;499:625–35. PubMed DOI PMC

Thams P, Capito K. L-Arginine stimulation of glucose-induced insulin secretion through membrane depolarization and independent of nitric oxide. Eur J Endocrinol. 1999;140:87–93. PubMed DOI

Leiss V, Flockerzie K, Novakovic A, Rath M, Schonsiegel A, Birnbaumer L, et al. Insulin secretion stimulated by L-arginine and its metabolite L-ornithine depends on G alpha(i2). Am J Phys. 2014;307:E800–12.

Docherty K, Carroll RJ, Steiner DF. Conversion of proinsulin to insulin: involvement of a 31,500 molecular weight thiol protease. Proc Natl Acad Sci U S A. 1982;79:4613–7. PubMed DOI PMC

Norrman M, Hubalek F, Schluckebier G. Structural characterization of insulin NPH formulations. Eur J Pharm Sci. 2007;30:414–23. PubMed DOI

Meijer AJ, Lamers WH, Chamuleau RAFM. Nitrogen-metabolism and ornithine cycle function. Physiol Rev. 1990;70:701–48. PubMed DOI

Aynsleygreen A, Alberti KGM. In-vivo stimulation of insulin-secretion by guanidine derivatives in rat. Horm Metab Res. 1974;6:115–20. DOI

Beaulieu JM, Gainetdinov RR. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev. 2011;63:182–217. PubMed DOI

Wise RA. Dopamine, learning and motivation. Nat Rev Neurosci. 2004;5:483–94. PubMed DOI

Callier S, Snapyan M, Le Crom S, Prou D, Vincent JD, Vernier P. Evolution and cell biology of dopamine receptors in vertebrates. Biol Cell. 2003;95:489–502. PubMed DOI

Eisenhofer G, Kopin IJ, Goldstein DS. Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol Rev. 2004;56:331–49. PubMed DOI

Ustione A, Piston DW, Harris PE. Minireview: dopaminergic regulation of insulin secretion from the pancreatic islet. Mol Endocrinol. 2013;27:1198–207. PubMed DOI PMC

Simpson N, Maffei A, Freeby M, Burroughs S, Freyberg Z, Javitch J, et al. Dopamine-mediated autocrine inhibitory circuit regulating human insulin secretion in vitro. Mol Endocrinol. 2012;26:1757–72. PubMed DOI PMC

Ustione A, Piston DW. Dopamine synthesis and D3 receptor activation in pancreatic beta-cells regulates insulin secretion and intracellular [Ca(2+)] oscillations. Mol Endocrinol. 2012;26:1928–40. PubMed DOI PMC

Ericson LE, Hakanson R, Lundquist I. Accumulation of dopamine in mouse pancreatic B-cells following injection of L-DOPA. Localization to secretory granules and inhibition of insulin secretion. Diabetologia. 1977;13:117–24. PubMed DOI

Rubi B, Ljubicic S, Pournourmohammadi S, Carobbio S, Armanet M, Bartley C, et al. Dopamine D2-like receptors are expressed in pancreatic beta cells and mediate inhibition of insulin secretion. J Biol Chem. 2005;280:36824–32. PubMed DOI

Wu WZ, Shang J, Feng Y, Thompson CM, Horwitz S, Thompson JR, et al. Identification of glucose-dependent insulin secretion targets in pancreatic beta cells by combining defined-mechanism compound library screening and siRNA gene silencing. J Biomol Screen. 2008;13:128–34. PubMed DOI

Garcia-Tornadu I, Ornstein AM, Chamson-Reig A, Wheeler MB, Hill DJ, Arany E, et al. Disruption of the dopamine D2 receptor impairs insulin secretion and causes glucose intolerance. Endocrinology. 2010;151:1441–50. PubMed DOI

Hoyer D, Hannon JP, Martin GR. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav. 2002;71:533–54. DOI

Berger M, Gray JA, Roth BL. The expanded biology of serotonin. Annu Rev Med. 2009;60:355–66. PubMed DOI PMC

Mawe GM, Hoffman JM. Serotonin signalling in the gut-functions, dysfunctions and therapeutic targets. Nat Rev Gastroenterol Hepatol. 2013;10:473–86. PubMed DOI PMC

Carhart-Harris RL, Nutt DJ. Serotonin and brain function: a tale of two receptors. J Psychopharmacol. 2017;31:1091–120. PubMed DOI PMC

Gershon MD. 5-Hydroxytryptamine (serotonin) in the gastrointestinal tract. Curr Opin Endocrinol. 2013;20:14–21. DOI

Jacobs BL, Azmitia EC. Structure and function of the brain-serotonin system. Physiol Rev. 1992;72:165–229. PubMed DOI

Cataldo Bascunan LR, Lyons C, Bennet H, Artner I, Fex M. Serotonergic regulation of insulin secretion. Acta Physiol. 2019;225:e13101. DOI

Falk B, Hellman B. Evidence for the presence of of biogenic amines in the pancreatic islets. Experientia. 1963;19:139–40. DOI

Falk B, Hellman B. A fluorescent reaction for monoamines in the insulin producing cells of the guinea-pig. Acta Endocrinol. 1964;45:133–8. DOI

Gylfe E. Association between 5-hydroxytryptamine release and insulin-secretion. J Endocrinol. 1978;78:239–48. PubMed DOI

Peschke E, Peschke D, Hammer T, Csernus V. Influence of melatonin and serotonin on glucose-stimulated insulin release from perifused rat pancreatic islets in vitro. J Pineal Res. 1997;23:156–63. PubMed DOI

Paulmann N, Grohmann M, Voigt JP, Bert B, Vowinckel J, Bader M, et al. Intracellular serotonin modulates insulin secretion from pancreatic beta-cells by protein serotonylation. PLoS Biol. 2009;7:e1000229. PubMed DOI PMC

Cataldo LR, Mizgier ML, Sagua RB, Jana F, Cardenas C, Llanos P, et al. Prolonged activation of the Htr2b serotonin receptor impairs glucose stimulated insulin secretion and mitochondrial function in MIN6 cells. PLoS One. 2017;12:e0170213. PubMed DOI PMC

Bennet H, Balhuizen A, Medina A, Nitert MD, Laakso EO, Essen S, et al. Altered serotonin (5-HT) 1D and 2A receptor expression may contribute to defective insulin and glucagon secretion in human type 2 diabetes. Peptides. 2015;71:113–20. PubMed DOI

Amisten S, Neville M, Hawkes R, Persaud SJ, Karpe F, Salehi A. An atlas of G-protein coupled receptor expression and function in human subcutaneous adipose tissue. Pharmacol Therapeut. 2015;146:61–93. DOI

Machackova K, Mlcochova K, Potalitsyn P, Hankova K, Socha O, Budesinski M, et al. Mutations at hypothetical binding site 2 in insulin and insulin-like growth factors 1 and 2 result in receptor- and hormone-specific responses. J Biol Chem. 2019;294:17371–82. PubMed DOI PMC

The final walk with preptin

A viral insulin-like peptide inhibits IGF-1 receptor phosphorylation and regulates IGF1R gene expression

Insulin receptor Arg717 and IGF-1 receptor Arg704 play a key role in ligand binding and in receptor activation

Non-glycosylated IGF2 prohormones are more mitogenic than native IGF2

Modulation of the antagonistic properties of an insulin mimetic peptide by disulfide bridge modifications

Characterization of insulin crystalline form in isolated β-cell secretory granules